Page last updated: 2024-08-25

narciclasine and Obesity

narciclasine has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chang, YH; Hung, HY1
Brunmeir, R; Garcia-Miralles, M; Ge, X; Han, W; Julien, SG; Kim, SY; Kn, BP; Li, H; Ma, W; McFarlane, C; Pouladi, MA; Röder, PV; Sim, CK; Sinnakannu, JR; Velan, SS; Wu, J; Xie, W; Xu, F; Yaligar, J; Zhang, Q1

Reviews

1 review(s) available for narciclasine and Obesity

ArticleYear
Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Animals; Anti-Obesity Agents; Drug Discovery; Obesity; Phytochemicals

2022

Other Studies

1 other study(ies) available for narciclasine and Obesity

ArticleYear
Narciclasine attenuates diet-induced obesity by promoting oxidative metabolism in skeletal muscle.
    PLoS biology, 2017, Volume: 15, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amaryllidaceae Alkaloids; AMP-Activated Protein Kinases; Animals; Biomarkers; Cell Respiration; Cells, Cultured; Cyclic AMP; Diet; Diet, High-Fat; Energy Metabolism; Enzyme Activation; Fatty Acids; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Muscle Fibers, Skeletal; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Obesity; Oxidation-Reduction; Phenanthridines; Physical Conditioning, Animal; Protective Agents; Reactive Oxygen Species; Signal Transduction

2017